2022 World Summit on Medical Technology: Pioneering Innovation at the Intersection of Technology and Healthcare

Science and technology are the primary productive forces, and innovation is the primary driving force for development. In the current era of increasingly frequent interdisciplinary advancements in science and technology, the cross-pollination and integration of technologies across various fields have brought about a growing number of innovative breakthroughs, and the healthcare sector is no exception. With the continuous innovation, integration, and upgrading of a series of technologies, the traditional healthcare and wellness industry is undergoing transformation inBiotechnology, Digital Information Technology, New Materials, and Intelligent Manufacturing TechnologyDriven by three core technologies, the industry has reached a new inflection point. China’s healthcare sector is ushering in an innovative growth paradigm of “Healthcare + X,” with cross-sector integration and convergent innovation emerging as the dominant trend in the development of the healthcare industry.

Hosted by VCBeat VB100, VCBeat Research Institute, and the Administrative Committee of Suzhou High-Tech Zone2022 World Summit on Medical TechnologyTo be held in Suzhou on December 14–15. Centered on the theme of empowering healthcare with technology, the conference will bring together nearly 100 distinguished guests, including leading domestic and international scientists and academic clinical experts, executives from pioneering enterprises and institutions, and forward-looking venture capital representatives, for a two-day event featuring“Platform for Sharing Cutting-Edge Technologies, Platform for Industrial Innovation Exchange, Platform for Showcasing Application Achievements”an annual industry gala integrating all these elements.

Where Is the Torrent of Generation X Sweeping Us Toward?

What Wisdom Supports and Empowers the Development of MedTech?

Swept along in the torrent of this era, we move forward with urgency. What new legends will next-generation medical technology write? This conference features"Generation X Era"Section, inviting top scientists to discuss developmental changes and future prospects in the current era;“IT×BT”The session will draw upon the rich resources of Suzhou High-Tech Zone, the Suzhou Institute of Biomedical Engineering and Technology (Chinese Academy of Sciences), Shanghai Changhai Hospital, and other institutions to share insights on cutting-edge topics such as innovative operational models for medical industry clusters, the transfer and commercialization of scientific and technological achievements in biomedical research, and clinical perspectives on the innovative R&D of heart valves. Investment firms, industrial service platforms, and industrial parks all serve as key pillars empowering corporate growth and industrial development. In“Technology × Ecology”This section guides readers through the innovative breakthroughs of listed companies and multinational giants, while offering insights into the discovery of emerging technologies from multiple perspectives, including venture capital.

The Growth and Development of Early-Stage Healthcare Projects,

How to Bridge the “Last Mile” in the Commercialization of Scientific and Technological Achievements?

At the beginning of this year, the newly revised "Law of the People's Republic of China on Progress in Science and Technology" ushered in a new chapter for the transformation of scientific and technological achievements in China. Promoting the translation of research findings and accelerating their industrialization have become new trends in China’s science and technology policies. The transformation of medical research achievements in China has now entered a golden age, with numerous laboratory research projects successfully commercialized and industrialized. This conference features“Scientist × Entrepreneur”Sector, designed to build a “tri-sector integration” exchange platform for scientists, venture capitalists, and entrepreneurs, and to identify high-quality projects. Invited participants includeLu Qianxing, Jingzhi FutureRepresentatives from five projects, focusing on cutting-edge technology and the translation of scientific achievements, shared the innovative journeys of medical scientists, promoted the widespread application of high-quality outcomes, and facilitated leapfrog development for outstanding enterprises.

The Deep Integration of Science and Technology with Medical Technology,

How to Expand the Scope of Multidisciplinary Applications?

With the development of life sciences and biotechnology, frontier biotechnological exploration is accelerating, and disruptive applications are continuously emerging. This conferenceApplications of Biotechnological InnovationsThis section will elucidate the new characteristics of global biopharmaceutical development from three perspectives: cell and gene therapy, IVD innovation, and AI-driven drug discovery. It further explores how IVD enterprises can forge ahead under heavy burdens in the post-pandemic era, with moreLu QianxingSharing based on personal experience; the digital health industry boasts prominent development advantages, inDigital Information Innovation and IntegrationThe session covers topics including the global expansion of innovative drugs, AI imaging, digital therapeutics, and digital health services, featuringCisco (China), Good Pregnancy for Life, Zhuhai Cloud Health (Quick Doctor Consultation), Clinical Research ConnectRepresentatives from leading enterprises will visit the site to engage in interactive exchanges with attendees; meanwhile, China’s medical device industry is experiencing a golden period of rapid development, and we are alsoNew Materials and Intelligent Manufacturing Establish New FoundationsExpansionSector: Exploring Opportunities and Challenges in the Market Penetration of Implantable and Interventional Medical Devices, with Invited Representatives from Leading Domestic Intelligent Rehabilitation Robotics CompaniesAngelaiPresent.

Conference Dates: December 14–15, 2022

Conference Venue: Suzhou, China

Organizers: VCBeat VB100, Eggshell Research Institute, Suzhou High-Tech Zone Administrative Committee

Co-organized by: Suzhou Yulu Qianxing Biotechnology Co., Ltd. and Cisco (China) Co., Ltd.

Conference Scale: 500 Attendees

(More guests to be confirmed...)

(More agenda items are still being confirmed......)

Scan the QR code to register and join the event instantly